FIELD: medicine, gastroenterology. SUBSTANCE: preparation comprises an alkaline hydrolytic lignin, 60-90 wt.-%; and lactulose, 10-40 wt.-%. The preparation shows good clinical results in lipid metabolism disorders, in viral and chronic hepatitis, disbacteriosis and total toxicosis of any etiology. EFFECT: enhanced effectiveness. 1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PREPARATION FOR TREATMENT OF PATIENTS WITH DISBACTERIOSIS AND GASTROENTERIC DISEASES | 1998 |
|
RU2131261C1 |
METHOD OF MEDICINAL LIGNIN PRODUCING | 1998 |
|
RU2131262C1 |
ENTEROSORBENT | 2005 |
|
RU2279278C2 |
PHARMACEUTICAL PREPARATION FOR INTESTINE BIOCOENOSIS NORMALISATION | 2007 |
|
RU2351344C2 |
METHOD OF PREPARING MEDICINAL LIGNIN | 1998 |
|
RU2140279C1 |
HEPATOPROTECTIVE PROBIOTIC AGENT | 2006 |
|
RU2310463C1 |
COMPOSITE ENTEROSORBENT | 2011 |
|
RU2491941C1 |
METHOD OF TREATMENT OF PATIENTS WITH ACUTE AND CHRONIC INTESTINAL DISEASES, REMEDY AND ITS FORM | 1998 |
|
RU2164143C2 |
COMPOSITION IN FORM OF SYRUP FOR BODY DETOXICATION | 2018 |
|
RU2716223C2 |
ENTEROSORBENT AND METHOD OF ITS OBTAINING | 2012 |
|
RU2514050C2 |
Authors
Dates
1999-06-10—Published
1998-10-14—Filed